Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07861399
NA

Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders

Sponsor: Al-Azhar University

View on ClinicalTrials.gov

Summary

To compare the embryological and reproductive outcomes of dual trigger versus conventional hCG trigger for final oocyte maturation in normal responder patients undergoing ICSI cycles.

Official title: Dual Trigger VS HCG Trigger for Final Oocyte Maturation in Normal Responders a Randomized Controlled Trial

Key Details

Gender

FEMALE

Age Range

20 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

100

Start Date

2026-09-01

Completion Date

2028-10

Last Updated

2026-10-06

Healthy Volunteers

No

Interventions

DRUG

Dual trigger (human chorionic gonadotropin plus GnRH-agonist)

Dual Trigger Group: Participants will receive a GnRH agonist combined with hCG for normal responders patients doing ICSI.

DRUG

hCG trigger

hCG Trigger Group: Participants will receive hCG alone the standard for normal responders doing ICSI.

Locations (1)

ART Unit, International Islamic Center for Population Studies and Research, Al-Azhar University

Cairo, Cairo Governorate, Egypt